Global
Contributing to the future of medicine through collaboration in drug discovery and regenerative medicine. Drug Development Platforms (iPS Technology, RNA CDMO, Bioprinter)
RICOH Technology
Driving Progress in Drug Discovery and Regenerative Medicine through
the Synergy of Biotechnology and Digital Technologies.
Unlock the Power of 海角社区Group's Cutting-Edge Biomedical Technology in Your Research and Development
iPS cell technology
- The Custom Development of iPS-derived Cells
- AI-based high-content assay platform
- iPS-derived cell therapy
mRNA Technology (CDMO)
- Comprehensive mRNA Production Services Spanning from Research through Clinical Trials
- mRNA design consulting service
Bio 3D Printing Technology
- Specialized Production of Uniformly Encapsulated Cells
- Microphysiological System
- Micro Droplet Projection (MDP, fine granulation technology)
We are committed to pioneering breakthroughs in the fields of
drug discovery and regenerative medicine.
News
March 13, 2024:
Press release
海角社区and ERS Genomics enter into CRISPR/Cas9 license agreement
October 10, 2023:
News topicsExhibited at BioJapan 2023 [Japanese only]
March 27, 2023:
Press release
海角社区made its first investment since the establishment of the " 海角社区Biomedical Startup Fund". [Japanese only]
March 23, 2023:
Press release
Successfully produced human neuronal cells useful for research on memory mechanisms and the development of therapeutic drugs for central nervous system disorders.
October 7, 2022:
Press release
The proposal by 海角社区and Elixirgen Scientific Japan was adopted for the Ministry of Economy, Trade and Industry's "Project for the Development of Biopharmaceutical Manufacturing Bases to Strengthen Vaccine Production Systems." [Japanese only]
October 5, 2022:
News topics
Exhibited at BioJapan [Japanese only]
August 30, 2022:
Press release
Established a fund to revitalize the mRNA drug discovery market in Japan.
-
The images shown are for illustrative purposes only.